Developing a Blood-Based Biomarker Panel for Alzheimer's Disease

About the Research Project
Program
Award Type
Postdoctoral Fellowship
Award Amount
$100,000
Active Dates
July 01, 2015 - December 31, 2017
Grant ID
A2015641F
Mentor(s)
Ralph Martins, PhD, Edith Cowan University
Goals
While much progress has been made over understanding Alzheimer’s disease (AD) pathology and using neuroprotective strategies and some effort spent on brain imaging changes in AD we still lag far behind in developing reliable, sensitive, non-invasive and cost-effective diagnostic biomarkers which can be used before and during the course of a therapeutic intervention. There is substantial evidence to indicate that early stages of Alzheimer’s Disease coincide with specific protein changes in peripheral body fluids particularly blood and these changes subsequently also reflect aggravation of AD pathology during its time-course. Age related protein changes pose a major hurdle to identify and differentiate the specific AD biomarkers due to high prevalence of the disease in aged populations. We propose that investigating familial form of AD will be an innovative approach to identify and develop reliable blood-based biomarkers for this disease.
Summary
While much progress has been made over understanding Alzheimer’s disease (AD) pathology and using neuroprotective strategies and some effort spent on brain imaging changes in AD we still lag far behind in developing reliable, sensitive, non-invasive and cost-effective diagnostic biomarkers which can be used before and during the course of a therapeutic intervention. There is substantial evidence to indicate that early stages of Alzheimer’s Disease coincide with specific protein changes in peripheral body fluids particularly blood and these changes subsequently also reflect aggravation of AD pathology during its time-course. Age related protein changes pose a major hurdle to identify and differentiate the specific AD biomarkers due to high prevalence of the disease in aged populations. We propose that investigating familial form of AD will be an innovative approach to identify and develop reliable blood-based biomarkers for this disease.
Related Grants
Alzheimer's Disease Research
Identifying New Memory and Brain Markers for Early Alzheimer's Disease
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Helena Gellersen, PhD
Current Organization
German Center for Neurodegenerative Diseases
Alzheimer's Disease Research
Staging Alzheimer's Disease Using Blood Samples
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Gemma Salvadó, PhD
Current Organization
Lund University
Alzheimer's Disease Research
Shining a Light on How Early Tau-Related Brain Changes Affect Memory Loss
Active Dates
July 01, 2024 - June 30, 2026

Principal Investigator
Martin Dahl, PhD
Current Organization
Max Planck Institute for Human Development (Germany)